Kevin Judice - Net Worth and Insider Trading

Kevin Judice Net Worth

The estimated net worth of Kevin Judice is at least $38 Million dollars as of 2024-11-05. Kevin Judice is the CEO of DICE Therapeutics Inc and owns about 799,685 shares of DICE Therapeutics Inc (DICE) stock worth over $38 Million. Details can be seen in Kevin Judice's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Judice has not made any transactions after 2023-05-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kevin Judice

To

Kevin Judice Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin Judice owns 2 companies in total, including Cidara Therapeutics Inc (CDTX) , and DICE Therapeutics Inc (DICE) .

Click here to see the complete history of Kevin Judice’s form 4 insider trades.

Insider Ownership Summary of Kevin Judice

Ticker Comapny Transaction Date Type of Owner
CDTX Cidara Therapeutics Inc 2015-04-14 director
DICE DICE Therapeutics Inc 2023-05-03 director & CEO

Kevin Judice Latest Holdings Summary

Kevin Judice currently owns a total of 1 stock. Kevin Judice owns 799,685 shares of DICE Therapeutics Inc (DICE) as of May 3, 2023, with a value of $38 Million.

Latest Holdings of Kevin Judice

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DICE DICE Therapeutics Inc 2023-05-03 799,685 47.55 38,025,022

Holding Weightings of Kevin Judice


Kevin Judice Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin Judice has made a total of 1 transactions in DICE Therapeutics Inc (DICE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in DICE Therapeutics Inc is the sale of 13,698 shares on May 3, 2023, which brought Kevin Judice around $499,977.

Insider Trading History of Kevin Judice

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin Judice Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kevin Judice Ownership Network

Ownership Network List of Kevin Judice

No Data

Ownership Network Relation of Kevin Judice

Insider Network Chart

Kevin Judice Owned Company Details

What does Cidara Therapeutics Inc do?

Who are the key executives at Cidara Therapeutics Inc?

Kevin Judice is the director of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include Chief Scientific Officer Leslie Tari , Chief Medical Officer Taylor Sandison , and director & President & CEO Jeffrey Stein .

Cidara Therapeutics Inc (CDTX) Insider Trades Summary

Over the past 18 months, Kevin Judice made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 30,407 shares made by Leslie Tari , a net sale of 40,379 shares made by Taylor Sandison , and a net purchase of 58,000 shares made by Jeffrey Stein .

In summary, during the past 3 months, insiders sold 1,833 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 1,833 shares. During the past 18 months, 7,751 shares of Cidara Therapeutics Inc (CDTX) were sold and 11,000 shares were bought by its insiders, resulting in a net purchase of 3,249 shares.

Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cidara Therapeutics Inc Insider Transactions

No Available Data

Kevin Judice Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin Judice. You might contact Kevin Judice via mailing address: 6310 Nancy Ridge Drive, San Diego Ca 92121.